Wedge Capital Management L L P NC Has $30.82 Million Position in Teleflex Incorporated $TFX

Wedge Capital Management L L P NC boosted its stake in shares of Teleflex Incorporated (NYSE:TFX) by 14.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 252,547 shares of the medical technology company’s stock after purchasing an additional 32,465 shares during the quarter. Wedge Capital Management L L P NC owned about 0.57% of Teleflex worth $30,821,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in TFX. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Teleflex by 57.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock worth $26,000 after buying an additional 77 shares during the last quarter. Hantz Financial Services Inc. raised its holdings in Teleflex by 248.8% in the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after acquiring an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new position in Teleflex during the 3rd quarter worth $35,000. Quent Capital LLC acquired a new position in Teleflex during the 3rd quarter worth $38,000. Finally, Cullen Frost Bankers Inc. boosted its holdings in Teleflex by 496.7% during the third quarter. Cullen Frost Bankers Inc. now owns 358 shares of the medical technology company’s stock valued at $44,000 after acquiring an additional 298 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Stock Up 5.2%

Shares of TFX opened at $116.23 on Friday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 2.01 and a current ratio of 2.54. The company has a 50-day simple moving average of $109.07 and a 200-day simple moving average of $116.76. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $141.91. The firm has a market capitalization of $5.14 billion, a P/E ratio of -5.66, a P/E/G ratio of 0.69 and a beta of 0.87.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share for the quarter, missing analysts’ consensus estimates of $3.73 by ($1.80). The firm had revenue of $569.00 million for the quarter, compared to analyst estimates of $912.57 million. Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The firm’s quarterly revenue was down 28.5% compared to the same quarter last year. During the same period last year, the business earned $3.89 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, equities research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th will be given a dividend of $0.34 per share. The ex-dividend date is Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.2%. Teleflex’s payout ratio is currently -6.62%.

Key Stories Impacting Teleflex

Here are the key news stories impacting Teleflex this week:

• Positive Sentiment: Irenic, a ~2% Teleflex shareholder, called for the Board to form a strategic-review sub‑committee with independent directors and to engage potential acquirers — a direct catalyst for takeover interest that can lift valuation expectations. Irenic Comments on Teleflex’s Announcement That It Is Open to Strategic Alternatives
• Positive Sentiment: Raymond James upgraded Teleflex from Market Perform to Outperform with a $128 price target, signaling analyst conviction that there’s upside from either operational improvement or strategic outcomes. Raymond James upgrade coverage
• Neutral Sentiment: Teleflex issued a formal statement reiterating its commitment to value‑maximizing strategies and said management met with Irenic on March 19 to understand their views — indicates engagement but not yet a formal review process. Teleflex Reiterates Commitment to Value‑Maximizing Strategies and Strong Execution
• Neutral Sentiment: Other shareholders and outlets are echoing calls for Teleflex to engage potential buyers, adding public pressure that could push the Board toward a more formal process. Teleflex shareholder urges company engage buyers
• Negative Sentiment: Teleflex pushed back, saying Irenic falsely claimed the company was not open to buyout offers — the public dispute raises governance/uncertainty risk and could deter some bidders or prolong a process. Teleflex says Irenic falsely claimed company was not open for buyout offers
• Negative Sentiment: Fundamentals remain a headwind: Teleflex reported a large recent earnings and revenue miss and guidance that reflects recovery needs — operational weakness could limit strategic options or depress standalone valuation until results improve.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. Royal Bank Of Canada raised their price target on Teleflex from $115.00 to $125.00 and gave the company a “sector perform” rating in a research report on Friday, February 27th. Wells Fargo & Company increased their target price on Teleflex from $116.00 to $130.00 and gave the company an “equal weight” rating in a research note on Friday, February 27th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Truist Financial lifted their price target on Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research report on Thursday, December 18th. Finally, Needham & Company LLC upped their price target on Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a report on Thursday, February 26th. Three analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $139.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.